Record NNP B-NP O
date NN I-NP O
: : O O
2090-12-13 CD O B-DATE
Pt NNP B-NP O
. . O O
of IN B-PP O
Dr. NNP B-NP O
Jaramillo NNP I-NP B-DOCTOR
presents VBZ B-VP O
for IN B-PP O
initial JJ B-NP O
visit NN I-NP O
as IN B-PP O
new JJ B-NP O
PCP. NNP I-NP O
He PRP B-NP O
is VBZ B-VP O
currently RB I-VP O
being VBG I-VP O
evaluated VBN I-VP O
for IN B-PP O
R NN B-NP O
leg NN I-NP O
claudication NN I-NP O
. . O O
He PRP B-NP O
reports VBZ B-VP O
having VBG I-VP O
pain NN B-NP O
inhis VBZ B-VP O
R NN B-NP O
leg NN I-NP O
after IN B-PP O
walking VBG B-VP O
for IN B-PP O
one CD B-NP O
block NN I-NP O
-- : O O
he PRP B-NP O
rests VBZ B-VP O
for IN B-PP O
a DT B-NP O
few JJ I-NP O
minutes NNS I-NP O
and CC O O
then RB O O
it PRP B-NP O
goes VBZ B-VP O
away RB B-ADVP O
. . O O
He PRP B-NP O
denies VBZ B-VP O
pain NN B-NP O
in IN B-PP O
his PRP$ B-NP O
left JJ I-NP O
leg NN I-NP O
. . O O
No DT B-NP O
CP NNP I-NP O
or CC I-NP O
SOB. NNP I-NP O
PROBLEMS NNS B-NP O
Hypothyroidism NN B-NP O
Seizure NNP B-NP O
disorder NN I-NP O
controlled VBN B-VP O
with IN B-PP O
dilantin-related JJ B-NP O
to TO B-PP O
AVM NNP B-NP O
-- : O O
occurred VBD B-VP O
9-10 CD B-NP O
yrs NNS I-NP O
ago IN O O
Noncongenital NN B-NP O
arteriovenous JJ I-NP O
malformation NN I-NP O
left VBD B-VP O
temporal JJ B-ADJP O
AVM . O O
Hyperlipidemia NNP B-NP O
Peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
Osteoporosis NN B-NP O
PSH NNP B-NP O
: : O O
Cholecystectomy NN B-NP O
in IN B-PP O
2060 CD B-NP I-DATE
's POS B-LST I-DATE
Appendectomy RB B-NP O
50 CD I-NP O
yrs NNS I-NP O
ago RB O O
ALLERGY NN B-NP O
NKDA NNP B-NP O
MEDICATIONS NNS B-NP O
LEVOXYL NNP B-NP O
( -LRB- I-NP O
LEVOTHYROXINE NNP I-NP O
SODIUM) NNP I-NP O
75MCG NNP I-NP O
1 CD I-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
DILANTIN NNP B-NP O
( -LRB- I-NP O
PHENYTOIN NN I-NP O
) -RRB- I-NP O
100MG CD I-NP O
1 CD I-NP O
Capsule( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
TID NN I-NP O
LIPITOR NNP B-NP O
( -LRB- I-NP O
ATORVASTATIN NNP I-NP O
) -RRB- I-NP O
10MG . B-VP O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QHS NNP B-NP O
30 CD I-NP O
day( NN I-NP O
s VBZ B-VP O
) -RRB- O O
FOSAMAX NN B-NP O
( -LRB- I-NP O
ALENDRONATE NNP I-NP O
) -RRB- I-NP O
70MG NNP I-NP O
1 CD I-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QWEEK NNP B-NP O
30 CD I-NP O
day( NN I-NP O
s VBZ B-VP O
) -RRB- O O
SH NNS B-NP O
: : O O
Smoked JJ B-NP O
2ppd JJ I-NP O
x NN I-NP O
35 CD B-NP O
yrs NNS I-NP O
and CC O O
stopped VBD B-VP O
15 CD B-NP O
yrs NNS I-NP O
ago RB B-ADVP O
; : O O
occ JJ B-NP O
wine NN I-NP O
with IN B-PP O
dinner NN B-NP O
; : O O
worked VBN B-VP O
before RB B-ADVP O
as IN B-PP O
a DT B-NP O
securities NNS I-NP B-PROFESSION
investment NN I-NP I-PROFESSION
broker NN I-NP I-PROFESSION
; : O O
lives NNS B-NP O
with IN B-PP O
wife NN B-NP O
and CC I-NP O
daughter NN I-NP O
ROS NNP B-NP O
: : O O
As IN B-PP O
per IN B-PP O
HPI NNP B-NP O
; : O O
denies VBZ B-NP O
GI NNP I-NP O
or CC I-NP O
GU NNP I-NP O
complaints NNS I-NP O
; : O O
reports NNS B-NP O
having VBG B-VP O
a DT B-NP O
rectal NN I-NP O
done VBN B-VP O
at IN B-PP O
his PRP$ B-NP O
last JJ I-NP O
PE NN I-NP O
with IN B-PP O
Dr. NNP B-NP O
Jaramillo NNP I-NP B-DOCTOR
; : O O
rest NN B-NP O
of IN B-PP O
ROS NNP B-NP O
unremarkable JJ I-NP O
. . O O
VS NNP B-NP O
: : O O
125/75 CD B-NP O
88 CD I-NP O
PE NN B-NP O
: : O O
General NNP B-NP O
-- : O O
alert JJ B-ADJP O
; : O O
no DT B-NP O
acute JJ I-NP O
distress NN I-NP O
Neck NNP B-NP O
-- : O O
no DT B-NP O
bruits NNS I-NP O
; : O O
no DT B-NP O
JVD NN I-NP O
Lungs NNP B-NP O
-- : O O
CTA NNP B-NP O
bilaterally CC O O
CV NNP B-NP O
-- : O O
RRR NNP B-NP O
; : O O
nml JJ B-NP O
s1s2 NN I-NP O
Abd NNP B-NP O
-- : O O
soft JJ O O
Rectal NNP B-NP O
-- : O O
refused VBD B-VP O
; : O O
said VBD B-VP O
Dr. NNP B-NP O
Jaramillo NNP I-NP B-DOCTOR
did VBD B-VP O
in IN B-NP O
10/90 CD I-NP B-DATE
Ext JJ B-NP O
-- : O O
L NNP B-NP O
DP NNP I-NP O
1+ VBD B-VP O
with IN B-PP O
good JJ B-NP O
LLE JJ I-NP O
cap NN I-NP O
refill NN I-NP O
; : O O
no DT B-NP O
RLE NN I-NP O
DP NNP I-NP O
pulse NN I-NP O
palpable NN I-NP O
11/12/90 CD B-NP B-DATE
LE JJ I-NP O
studies NNS I-NP O
Test JJ B-NP O
today NN I-NP O
demonstrates VBZ B-VP O
A-I JJ B-NP O
disease NN I-NP O
( -LRB- O O
worse JJR B-NP O
on IN B-PP O
the DT B-NP O
right NN I-NP O
) -RRB- B-NP O
, , I-NP O
right JJ I-NP O
SFA NNP I-NP O
occlusion NN I-NP O
and CC I-NP O
right JJ I-NP O
distal JJ I-NP O
popliteal/tibial NN I-NP O
vesssel NN I-NP O
disease NN I-NP O
. . O O
On IN B-PP O
the DT B-NP O
right JJ I-NP O
, , I-NP O
patient JJ I-NP O
is VBZ B-VP O
fairly RB I-VP O
well RB I-VP O
collateralized VBN I-VP O
across IN B-PP O
the DT B-NP O
ankl NN I-NP O
level NN I-NP O
at IN B-PP O
rest NN B-NP O
and CC O O
poorly RB B-ADVP O
after IN B-PP O
4.5 CD B-NP O
minutes NNS I-NP O
of IN B-PP O
exercise NN B-NP O
. . O O
On IN B-PP O
the DT B-NP O
left JJ I-NP O
, , I-NP O
patient NN I-NP O
is VBZ B-VP O
well RB B-ADJP O
collateralized VBN I-ADJP O
across IN B-PP O
the DT B-NP O
ankle NN I-NP O
level NN I-NP O
at IN B-PP O
rest NN B-NP O
and CC O O
after IN B-NP O
4.5 CD I-NP O
minutes NNS I-NP O
of IN B-PP O
exercise NN B-NP O
. . O O
10/17/90 CD B-NP B-DATE
TSH NNP I-NP O
and CC I-NP O
chem NN I-NP O
7 CD I-NP O
WNL NNP I-NP O
; : O O
Dilantin NNP B-NP O
level NN I-NP O
stable NN I-NP O
A/P NNP B-NP O
: : O O
76 CD B-NP B-AGE
yo NNP I-NP O
male NN I-NP O
hx NN I-NP O
seizure NN I-NP O
d/o NN I-NP O
s/p NN I-NP O
ICH NNP I-NP O
, , I-NP O
hypothyroidism NN I-NP O
, , I-NP O
hyperlipidemia NN I-NP O
, , O O
PVD NNP B-NP O
presents VBZ B-VP O
for IN B-PP O
general JJ B-NP O
f/u NN I-NP O
. . O O
Found VBN B-VP O
to TO I-VP O
have VB I-VP O
RLE NNP B-NP O
arterial JJ I-NP O
disease NN I-NP O
. . O O
1 LS O O
. . B-NP O
PV NNP I-NP O
-- : O O
will MD B-VP O
refer VB I-VP O
to TO B-PP O
Dr. NNP B-NP O
Uddin NNP I-NP B-DOCTOR
for IN B-PP O
further JJ B-NP O
eval NN I-NP O
. . O O
Not RB O O
on IN B-PP O
ASA NNP B-NP O
due JJ I-NP O
to TO B-VP O
hx VB I-VP O
ICH NNP B-NP O
-- : O O
will MD B-VP O
ask VB I-VP O
his PRP$ B-NP O
Neurologist NN I-NP O
Dr. NNP I-NP O
Acuna NNP I-NP B-DOCTOR
if IN B-PP O
trental JJ B-NP O
OK JJ I-NP O
before IN I-NP O
starting VBG I-NP O
2. DT B-NP O
Hyperlipidemia NNP I-NP O
-- : O O
check VBP B-VP O
fasting VBG I-VP O
lipids NNS B-NP O
and CC I-NP O
LFTs NNS I-NP O
this DT B-NP O
week NN I-NP O
; : O O
continue VB B-VP O
current JJ B-NP O
Lipitor NNP I-NP O
dose NN I-NP O
3. DT B-NP O
Endo NNP I-NP O
-- : O O
continue VBP B-VP O
current JJ B-NP O
Synthroid NNP I-NP O
dose NN I-NP O
4 CD B-LST O
. . O O
Neuro NNP B-NP O
-- : O O
pt NN B-NP O
's POS B-NP O
level NN I-NP O
has VBZ B-VP O
always RB I-VP O
been VBN I-VP O
in IN B-PP O
this DT B-NP O
range NN I-NP O
, , O O
so RB B-ADVP O
wo MD B-VP O
n't RB I-VP O
change VB I-VP O
at IN B-PP O
this DT B-NP O
time NN I-NP O
5 CD B-NP O
. . O O
HCM NNP B-NP O
-- : O O
continue VBP B-VP O
Fosamax NNP B-NP O
; : O O
will MD B-VP O
pursue VB I-VP O
GI JJ B-NP O
studies NNS I-NP O
in IN B-PP O
future JJ B-NP O
visits NNS I-NP O
RTC NNP B-NP O
2-3 CD I-NP O
months NNS I-NP O
Debra NNP B-NP B-DOCTOR
A. NN I-NP I-DOCTOR
Rosenberg NNP I-NP I-DOCTOR
, , O O
M.D. NNP B-NP O
